|
BRAVECTO CHEWABLE TABLETS (Each chewable tablets contains Fluralaner 1000mg)
Fluralaner
|
Fluralaner
1000mg
|
Ghana
|
FDA/V.255-10166
|
Valid
|
|
BRAVECTO CHEWABLE TABLETS (Each chewable tablets contains Fluralaner 112.5mg)
Fluralaner
|
Fluralaner
112.5mg
|
Ghana
|
FDA/V.255-10165
|
Valid
|
|
BRAVECTO CHEWABLE TABLETS (Each chewable tablets contains Fluralaner 1400mg)
Fluralaner
|
Fluralaner
1400mg
|
Ghana
|
FDA/V.255-10164
|
Valid
|
|
BRAVECTO CHEWABLE TABLETS (Each chewable tablets contains Fluralaner 250mg)
Fluralaner
|
Fluralaner
250mg
|
Ghana
|
FDA/V.255-10163
|
Valid
|
|
BRAVECTO CHEWABLE TABLETS (Each chewable tablets contains Fluralaner 500mg)
Fluralaner
|
Fluralaner
500mg
|
Ghana
|
FDA/V.255-10162
|
Valid
|
|
Bravecto 112.5 Chewable Tablets
Fluralaner 111.85 mg
|
Tablet Uncoated
111.85 mg
|
Zambia
|
ZAMRA-VM-23-53
|
Registered/Compliant
|
|
FERTAGYL
Gonadorelin 0.1 mg/ml mg/ml
|
Suspension for Injection
0.1 mg/ml mg/ml
|
Zambia
|
ZAMRA-VM-26-103
|
Registered/Compliant
|
|
FORTEGRA VACCINE 1000 & 10000 DOSES SUSPENSION FOR ORAL ADMINISTRATION (LIVE OOCYSTS OF THE FOLLOWING SPECIES OF COCCIDIA: MIN COUNT 600 OOCYTES EIMERIA ACERVULINA, 200 OOCYTES EIMERIA MAXIMA, 100 OOCYTES EIMERIA MAXIMA MFP, 400 OOCYTES EIMERIA MIVAFI, 200 OOCYTES EIMERIA TENELLA)
LIVE OOCYSTS OF THE FOLLOWING SPECIES OF COCCIDIA: MIN COUNT 600 OOCYTES EIMERIA ACERVULINA, 200 OOCYTES EIMERIA MAXIMA, 100 OOCYTES EIMERIA MAXIMA MFP, 400 OOCYTES EIMERIA MIVAFI, 200 OOCYTES EIMERIA TENELLA
|
LIVE OOCYSTS OF THE FOLLOWING SPECIES OF COCCIDIA: MIN COUNT 600 OOCYTES EIMERIA ACERVULINA, 200 OOCYTES EIMERIA MAXIMA, 100 OOCYTES EIMERIA MAXIMA MFP, 400 OOCYTES EIMERIA MIVAFI, 200 OOCYTES EIMERIA TENELLA
1000DOSE/4ML & 1000 DOSES/10ML
|
Ghana
|
FDA/VVC/255-07021
|
Valid
|
|
M+PAC
Mycoplasma hyopneumonia 1 ml
|
Emulsion for injection
1 ml
|
Zambia
|
ZAMRA-VM-26-34
|
Registered/Compliant
|
|
Multivax P Plus
C. chauvoei Toxoid 6-12 mg/gm,C. novyi type B toxoid Toxoid 8-160 mg/gm,C. perfringens type C toxoid Toxoid 30-60 mg/gm,C. perfringens type D toxoid Toxoid 80-160 mg/gm,C. septicum toxoid Toxoid 3-6 mg/gm,C. tetani toxoid Toxoid 6-12 mg/gm,Mannheimia haemolytica Strain NL 1009 5x10^5 mg/gm
|
Liquid for injection
5x10^5 mg/gm,Toxoid 3-6 mg/gm,Toxoid 30-60 mg/gm,Toxoid 6-12 mg/gm,Toxoid 8-160 mg/gm,Toxoid 80-160 mg/gm
|
Zambia
|
ZAMRA-VM-26-26
|
Registered/Compliant
|
|
NOBILIS DAPPVL2 VACCINE (LIVE VIRUS VACCINE COMBINED WITH AN INACTIVATED LEPTOSPIRA CANICOLA AND LEPTOSPIRA ICTEROHAEMORRHAGIAE BACTERIA; EACH 1ML/DOSE OF VACCINE CONTAINS CANINE DISTEMPER VIRUS (CDV), DISTEMPEROID STRAIN⩾103.7 TC1D₅₀, CANINE ADENOVIRUS TYPE 2 (CAV-2), DITCHFIELD STRAIN ⩾104.8 TC1D₅₀, CANINE PARAINFLUENZA (CPI), CPI-PR STRAIN ⩾104.3 TC1D₅₀, CANINE PARVOVIRUS (CPV), SAH-CPV-2B STRAIN ⩾ 105.1 FA1D₅₀, LEPTOSPIRA CANICOLA (LC), LC-N4 STRAIN ⩾ 80 HAMSTER PD80, LEPTOSPIRA ICTEROHAEMORRHAGIAE (LD LI-11403 J STRAIN ⩾ 80 HAMSTER P080
CANINE DISTEMPER VIRUS (CDV), DISTEMPEROID STRAIN, CANINE ADENOVIRUS TYPE 2 (CAV-2), DITCHFIELD STRAIN , CANINE PARAINFLUENZA (CPI), CPI-PR STRAIN, CANINE PARVOVIRUS (CPV), SAH-CPV-2B STRAIN, LEPTOSPIRA CANICOLA (LC), LC-N4 STRAIN HAMSTER PD80, LEPTOSPIRA ICTEROHAEMORRHAGIAE (LD LI-11403 J STRAIN HAMSTER PD80
|
CANINE DISTEMPER VIRUS (CDV), DISTEMPEROID STRAIN, CANINE ADENOVIRUS TYPE 2 (CAV-2), DITCHFIELD STRAIN , CANINE PARAINFLUENZA (CPI), CPI-PR STRAIN, CANINE PARVOVIRUS (CPV), SAH-CPV-2B STRAIN, LEPTOSPIRA CANICOLA (LC), LC-N4 STRAIN HAMSTER PD80, LEPTOSPIRA ICTEROHAEMORRHAGIAE (LD LI-11403 J STRAIN HAMSTER PD80
EACH 1ML/DOSE OF VACCINE CONTAINS CANINE DISTEMPER VIRUS (CDV), DISTEMPEROID STRAIN⩾103.7 TC1D₅₀, CANINE ADENOVIRUS TYPE 2 (CAV-2), DITCHFIELD STRAIN ⩾104.8 TC1D₅₀, CANINE PARAINFLUENZA (CPI), CPI-PR STRAIN ⩾104.3 TC1D₅₀, CANINE PARVOVIRUS (CPV), SAH-CPV-2B STRAIN ⩾ 105.1 FA1D₅₀, LEPTOSPIRA CANICOLA (LC), LC-N4 STRAIN ⩾ 80 HAMSTER PD80, LEPTOSPIRA ICTEROHAEMORRHAGIAE (LD LI-11403 J STRAIN ⩾ 80 HAMSTER P080
|
Ghana
|
FDA/VVC/255-08038
|
3 months to expiry
|
|
NOBILIS® IB+ND VACCINE
Inactivated infectious bronchitis virus Massachussetts type 6log2HI Units,Inactivated Newcastle Disease Virus 50 PD50 Units
|
Water in oil emulsion
50 PD50 Units,6log2HI Units
|
Zambia
|
331/720V
|
Registered/Compliant
|
|
NOBIVAC RABIES VACCINE
2% AlPO4 0,15 ml,Maintenance medium 0,8 ml,Na2HPO4.2H2O 5 mg/6 mL,NaH2PO4.2H2O 0,9 mg/6 mL,Purified Water. 0,05 ml,Rabies virus inactivated antigen suspension > 0.95 AIU* equivalent to>2.0 IU,Thiomersal 0,01 – 0,02 %
|
Suspension for injection
0.95
|
Tanzania
|
TAN 24 V 0392
|
Registered/Compliant
|
|
Nobilis MG 6/85
strain 6/85 of Mycoplasma gallisepticum at least 106,9 CFU CFU
|
Freeze dried pellet for injection after reconstitution
at least 106,9 CFU CFU
|
Zambia
|
ZAMRA-VM-26-208
|
Registered/Compliant
|
|
Nobilis® Corvac 4
A. paragalinarum - strain 083 (serotype A) At least 1CPD70 microgram,A. paragalinarum - strain 48 (serotype variant type B) At least 1CPD70 microgram,A. paragalinarum - strain H-18 (serotype C ) At least 1CPD70 microgram,A. paragalinarum - strain spross (serotype B) At least 1 CPD70 microgram
|
Suspension for Injection
At least 1 CPD70 microgram,At least 1CPD70 microgram
|
Zambia
|
331/704V
|
Registered/Compliant
|
|
Nobilis® IB Ma5 Vaccine
Live Infectious Bronchitis Virus strain Ma5 0,67 ml
|
Suspension
|
Tanzania
|
TAN 26 V 0156
|
Registered/Compliant
|
|
Nobivac® Rabies 10-Dose
Rabies virus inactivated antigen suspension ≥ 0,95 AIU* equivalent to ≥ 2,0 I.U.** ml
|
Suspension for injection
≥ 0,95 AIU equivalent to ≥ 2.0 I.U
|
Tanzania
|
TAN 25 V 0484
|
Registered/Compliant
|
|
PANACUR AQUASOL ORAL SOLUTION (Each ml contains Febendazole 200mg)
Febendazole
|
Febendazole
200mg
|
Ghana
|
FDA/V.255-09149
|
Valid
|
|
Univax-BD
Infectious Bursal Disease Virus ≥10^2.3 TCID50 Units
|
lyophilized powder
≥10^2.3 TCID50 Units
|
Zambia
|
ZAMRA-VM-26-32
|
Registered/Compliant
|